Archives for: June 22nd, 2015

CorMedix Inc. to Join Russell Global and Russell 3000 Indexes

Written by Welcome on June 22, 2015

BEDMINSTER, N.J., June 22, 2015 — CorMedix Inc. (NYSE MKT:…

CorMedix Inc. Receives Positive Feedback from FDA for Neutrolin® Clinical Trial Protocol for Oncology Patients

Written by Welcome on June 17, 2015

BEDMINSTER, N.J., June 17, 2015 — CorMedix Inc. (NYSE MKT:…

CorMedix Presents Neutrolin® Post Marketing Surveillance Data at European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Conference

Written by Welcome on June 1, 2015

BEDMINSTER, N.J., June 1, 2015 — CorMedix Inc. (NYSE MKT:…